Cogent Biosciences, Inc.
COGT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622229
In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Cogent Biosciences, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 144
- +12 vs. Q3 2023
- Shares held
- 90.8M
- +118.8K (+0.1%) vs. Q3 2023
- Total value
- $534.0M
- −$350.2M (−39.6%) vs. Q3 2023
- New holders
- 36
- 61 more added
- Sold out
- 24
- 30 more reduced
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COGT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 322 | $7.50B |
| Q1 2026 | 305 | $7.17B |
| Q4 2025 | 267 | $6.18B |
| Q3 2025 | 195 | $2.29B |
| Q2 2025 | 181 | $973.2M |
| Q1 2025 | 186 | $799.6M |
| Q4 2024 | 177 | $949.5M |
| Q3 2024 | 161 | $1.32B |
| Q2 2024 | 149 | $1.02B |
| Q1 2024 | 146 | $734.3M |
| Q4 2023 | 144 | $534.0M |
| Q3 2023 | 135 | $885.8M |
| Q2 2023 | 136 | $1.05B |
| Q1 2023 | 137 | $810.4M |
| Q4 2022 | 135 | $864.1M |
| Q3 2022 | 134 | $1.10B |
| Q2 2022 | 112 | $633.3M |
| Q1 2022 | 86 | $353.6M |
| Q4 2021 | 82 | $385.2M |
| Q3 2021 | 73 | $309.6M |
| Q2 2021 | 69 | $293.7M |
| Q1 2021 | 69 | $303.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Cogent Biosciences, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Candriam Luxembourg S.C.A. | 232,487 | $1.37M | 0.01% | −545,000−70.1% | Reduced |
| Nuveen Asset Management, LLC | 244,748 | $1.44M | 0.00% | +23,371+10.6% | Added |
| New Leaf Venture Partners, L.L.C. | 250,765 | $1.47M | 1.19% | −250,765−50.0% | Reduced |
| Sphera Funds Management Ltd. | 259,201 | $1.52M | 0.28% | −160,799−38.3% | Reduced |
| Schonfeld Strategic Advisors LLC | 260,955 | $1.53M | 0.01% | +23,425+9.9% | Added |
| HighVista Strategies LLC | 281,093 | $1.65M | 0.60% | +82,506+41.5% | Added |
| Rafferty Asset Management, LLC | 288,671 | $1.70M | 0.01% | +96,894+50.5% | Added |
| Bank of New York Mellon Corp | 300,899 | $1.77M | 0.00% | +12,692+4.4% | Added |
| SG Americas Securities, LLC | 317,409 | $1.87M | 0.02% | +212,687+203.1% | Added |
| Kennedy Capital Management, Inc. | 320,316 | $1.88M | 0.04% | +53,782+20.2% | Added |
| Algert Global LLC | 355,570 | $2.09M | 0.08% | +252,495+245.0% | Added |
| Goldman Sachs Group Inc | 446,772 | $2.63M | 0.00% | +46,890+11.7% | Added |
| Platinum Investment Management Ltd | 475,634 | $2.80M | 0.11% | −2030.0% | Reduced |
| Polar Asset Management Partners Inc. | 495,200 | $2.91M | 0.08% | +495,200 | New |
| Assenagon Asset Management S.A. | 600,764 | $3.53M | 0.01% | −8,134−1.3% | Reduced |
| Charles Schwab Investment Management Inc | 606,029 | $3.56M | 0.00% | +13,537+2.3% | Added |
| Citadel Advisors LLC | 640,771 | $3.77M | 0.00% | +580,166+957.3% | Added |
| Nantahala Capital Management, LLC | 640,936 | $3.77M | 0.38% | +65,936+11.5% | Added |
| Northern Trust Corp | 713,587 | $4.20M | 0.00% | +725+0.1% | Added |
| Saturn V Capital Management LLC | 756,681 | $4.45M | 1.70% | −1,018,734−57.4% | Reduced |
| 5AM Venture Management, LLC | 790,440 | $4.65M | 1.23% | 00.0% | Unchanged |
| Woodline Partners LP | 790,484 | $4.65M | 0.05% | +670,484+558.7% | Added |
| Silverarc Capital Management, LLC | 966,748 | $5.68M | 1.75% | +315,376+48.4% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,089,345 | $6.41M | 0.12% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,122,958 | $6.60M | 0.15% | −1,186,512−51.4% | Reduced |
| Dimensional Fund Advisors LP | 1,636,834 | $9.62M | 0.00% | +57,143+3.6% | Added |
| Geode Capital Management, LLC | 1,728,782 | $10.2M | 0.00% | +81,536+4.9% | Added |
| Frazier Life Sciences Management, L.P. | 1,995,267 | $11.7M | 0.63% | +493,884+32.9% | Added |
| Eventide Asset Management, LLC | 2,232,968 | $13.1M | 0.21% | +82,968+3.9% | Added |
| Vivo Capital, LLC | 2,244,941 | $13.2M | 1.08% | 00.0% | Unchanged |
| Morgan Stanley | 2,259,201 | $13.3M | 0.00% | +2,129,702+1,644.6% | Added |
| Millennium Management LLC | 2,797,244 | $16.4M | 0.02% | +2,673,555+2,161.5% | Added |
| Redmile Group, LLC | 2,914,022 | $17.1M | 0.61% | +860,689+41.9% | Added |
| Fairmount Funds Management LLC | 3,558,975 | $20.9M | 2.21% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,710,539 | $21.8M | 1.00% | +657,239+21.5% | Added |
| State Street Corp | 4,150,615 | $24.4M | 0.00% | +1,182,980+39.9% | Added |
| Vanguard Group Inc | 4,534,655 | $26.7M | 0.00% | +161,344+3.7% | Added |
| VR Adviser, LLC | 4,684,167 | $27.5M | 1.89% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 5,191,448 | $30.5M | 0.09% | +1,424,693+37.8% | Added |
| FMR LLC | 5,302,854 | $31.2M | 0.00% | +733,073+16.0% | Added |
| Commodore Capital LP | 5,566,026 | $32.7M | 2.86% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 5,631,042 | $33.1M | 3.67% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 5,854,766 | $34.4M | 3.90% | +3,644,641+164.9% | Added |
| BlackRock Inc. | 6,755,584 | $39.7M | 0.00% | +608,506+9.9% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −6,416,147−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −1,292,966−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,036,069−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −552,908−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −525,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −235,000−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −225,605−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −125,638−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −85,000−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −62,766−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −38,652−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −27,100−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −23,224−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −10,318−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −10,111−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,629−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −271−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −245−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −122−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |
| Pathstone Family Office, LLC | – | – | – | – | Not filed |
| Innovis Asset Management LLC | – | – | – | – | Not filed |